PubMed · 1993 · 155 citations · 0 references
MedicineNephrologyNutritional SciencesDialysisHemodialysisMicronutrient NutritionChronic Kidney DiseaseDialysis PharmacotherapyFolate DeficiencyPyridoxine TherapyRenal DiseaseRenal NutritionCholesterol Lowering PreventionCholesterol-lowering EffectsHomocysteine ElevationLipid-lowering Therapy In DialysisNutrition In HemodialysisPeritoneal Dialysis CarePyridoxine SupplementationSerum Folate Status
Pyridoxine and folic acid supplementation in dialysis patients is a matter of debate. This study was performed to estimate the effects of pharmacologic doses of these vitamins on serum lipid and plasma homocysteine concentrations, which are known to be high in dialysis patients. Both hemodialysis and continuous ambulatory peritoneal dialysis patients were included in the study. Pyridoxine supplementation had a mild but significant cholesterol-lowering effect (7%). Folic acid supplementation significantly lowered plasma homocysteine concentrations by a mean of 30%. There was a strong, inverse correlation between blood folate and plasma homocysteine concentrations. These results indicate that daily supplementation with pyridoxine 300 mg and folic acid 5 mg has a beneficial effect on the cardiovascular risk profile in dialysis patients.